PADI4 and chronic obstructive pulmonary disease: To improve the translational relevance and clinical impact of PAD4 inhibition in COPD, further efforts are needed to develop highly potent and selective PAD4 inhibitors while conducting rigorous preclinical studies in appropriate models.